Logo
P

ProBio

191 employees

ProBio is a global contract development and manufacturing (CDMO) organization, which aims to accelerate the manufacturing of life-changing drugs, discover novel therapeutic targets, and develop innovative therapeutic approaches to manufacture best-in-class DNA, RNA, and protein-based therapeutics. As a global partner, ProBio brings together multi-disciplinary expertise to accelerate the manufacturing of advanced therapies, including biologics, protein and mRNA vaccines, viral vectors, antibody-drug conjugates and drug discovery services. We aid you in realizing the potential of your breakthrough discovery to treat diseases and improve lives. Let us accelerate your path to market with the greatest chance of success!

Investor insights

Funding rounds participated in

$220M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2020

Funding rounds raised

Total raised

$220M

from 2 investors over 1 rounds

P

ProBio raised $220M on February 18, 2023

Investors: Legend Capital and + 6 Other investors

FAQ